Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations

Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations

Non-small-cell lung cancer (NSCLC) is the primary cause of cancer-related death. Gene rearrangements involving the anaplastic lymphoma kinase (ALK) tyrosine kinase identify a clinical and molecular subset of NSCLC patients, who benefit from the monotherapy with ALK tyrosine kinase inhibitors. Noneth...

Full description

Bibliographic Details
Main Authors: Matteo Canale, Elisabetta Petracci, Paola Cravero, Marita Mariotti, Gabriele Minuti, Giulio Metro, Vienna Ludovini, Sara Baglivo, Maurizio Puccetti, Alessandra Dubini, Giovanni Martinelli, Angelo Delmonte, Lucio Crinò, Paola Ulivi
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Translational Oncology
Subjects:
Non-small cell lung cancer (NSCLC)
Anaplastic lymphoma kinase (ALK) gene re-arrangements
Tumor protein 53 (TP53) gene mutations
Prognosis
Therapy resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322001309

Internet

http://www.sciencedirect.com/science/article/pii/S1936523322001309

Similar Items